Daily Market Reports | 10:50 AM
An additional news report on the recommendation, valuation, forecast and opinion changes and updates for ASX-listed equities.
In addition to The Australian Broker Call Report, which is published and updated daily (Mon-Fri), FNArena has now added The Australian Broker Call *Extra* Edition, featuring additional sources of research and insights on ASX-listed stocks, also enlarging the number of stocks that make up the FNArena universe.
One key difference is the *Extra* Edition will not be updated daily, but merely "regularly" depending on availability of suitable quality content. As such, the *Extra* Edition tries to build a bridge between daily updates via the Australian Broker Call Report and ad hoc news stories, that are not always timely for investors hungry for the next information update.
Investors using the *Extra* Edition as a source of input for their own share market research should thus take into account that information after publication may not be up to date, or yet awaiting another update by FNArena's team of journalists.
Similar to The Australian Broker Call Report, this *Extra* Edition includes concise but limited reviews of research recently published by Stockbrokers and other experts, which should be considered as information concerning likely market behaviour rather than advice on the securities mentioned. Do not act on the contents of this Report without first reading the important information included at the end of this Report.
The Australian Broker Call *Extra* Edition is a summary that has been prepared independently of the sources identified. Readers will check the full text of the recommendations and consult a Licenced Advisor before making any investment decision.
The copyright of this Report is owned by the publisher. Readers will not copy, forward or disseminate this Report to any other person. For more vital information about the sources included, see the bottom of this Report.
COMPANIES DISCUSSED IN THIS ISSUE
Click on a symbol for fast access.
The number next to the symbol represents the number of brokers covering it for this report -(if more than 1)
ABB ACE AEL ARF BMN BOE BVS CAR CIP CPU CSL DYL EVN FBU HDN JHX LAM MM1 MQG NSR NWS PDN PEN PSC RGN RKN SLX SPG STO TPG TPW TWE WEB (2)
RGN REGION GROUP
REITs - Overnight Price: $2.27
Jarden rates ((RGN)) as Neutral (3) -
Jarden observes Region Group announced an in-line 1H26 with FY26 FFO guidance upgraded to 16.0c from 15.9c.
Net operating income guidance of 3.3% growth appears conservative (1H26 3.7%) and should be supported by positive leasing outcomes.
The REIT's capital management increased medium-term hedging protection with FY28 hedging rising to 70% from 56%. The broker's FFO assumptions for FY29 onwards have been revised lower by around 4% as hedging rolls off.
Jarden retains a Neutral rating and lowers the target price to $2.55 from $2.65.
This report was published on February 11, 2026.
Target price is $2.55 Current Price is $2.27 Difference: $0.28
If RGN meets the Jarden target it will return approximately 12% (excluding dividends, fees and charges).
Current consensus price target is $2.37, suggesting upside of 4.5%(ex-dividends)
Forecast for FY26:
Current consensus EPS estimate is 15.8, implying annual growth of -13.6%.
Current consensus DPS estimate is 14.1, implying a prospective dividend yield of 6.2%.
Current consensus EPS estimate suggests the PER is 14.4.
Forecast for FY27:
Current consensus EPS estimate is 16.5, implying annual growth of 4.4%.
Current consensus DPS estimate is 14.7, implying a prospective dividend yield of 6.5%.
Current consensus EPS estimate suggests the PER is 13.8.
Market Sentiment: 0.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
RKN RECKON LIMITED
Accountancy - Overnight Price: $0.53
Moelis rates ((RKN)) as Buy (1) -
Moelis keeps Reckon on Buy with a target of $1.05, arguing the stock’s discounted multiples largely reflect strategic constraints under a legacy Intuit licence.
2025 earnings exceeded the broker’s estimates on cost discipline and higher margins, prompting a rebasing of costs and a 13.9% uplift to 2026 forecast earnings.
Moelis sees re-rating potential if management can accelerate customer migration to the proprietary Reckon One platform over the next 2–3 years, with an Inventory module planned for 2026 to bridge functionality gaps and enable faster migration.
The broker notes accounting subscriber numbers were flat in 1H25 yet ARPU continued to rise and net debt fell, while Legal division momentum lifted segment revenue growth to over 12% and Zebraworks shows early traction with circa 5,000 attorneys.
Commentary points to scope to nearly double billing services ARR from $1.4m in 2026E as installations convert to billing revenue.
This report was published on February 10, 2026.
Target price is $1.05 Current Price is $0.53 Difference: $0.52
If RKN meets the Moelis target it will return approximately 98% (excluding dividends, fees and charges).
The company's fiscal year ends in December.
Forecast for FY26:
Moelis forecasts a full year FY26 dividend of 2.50 cents and EPS of 6.40 cents.
At the last closing share price the estimated dividend yield is 4.72%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 8.28.
Forecast for FY27:
Moelis forecasts a full year FY27 dividend of 2.50 cents and EPS of 7.40 cents.
At the last closing share price the estimated dividend yield is 4.72%.
At the last closing share price the stock's estimated Price to Earnings Ratio (PER) is 7.16.
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
SLX SILEX SYSTEMS LIMITED
Uranium - Overnight Price: $6.65
Canaccord Genuity rates ((SLX)) as Speculative Buy (1) -
Canaccord Genuity raises its target price to $10.48 from $9.42 and retains a Speculative Buy rating on Silex Systems post a change in the broker's outlook for demand and supply on uranium prices.
The broker argues a step change in energy demand is emerging for the first time since the early 2000s, with sentiment now strongly supportive of nuclear across both public and private markets.
Despite rising demand, the broker notes uranium supply concerns remain unresolved with tightening conditions beginning to show through in the long term market.
Canaccord Genuity lifts the long term uranium price assumption to US$110/lb from 2030.
This report was published on February 8, 2026.
Target price is $10.48 Current Price is $6.65 Difference: $3.83
If SLX meets the Canaccord Genuity target it will return approximately 58% (excluding dividends, fees and charges).
Market Sentiment: 1.0
All consensus data are updated until yesterday. FNArena's consensus calculations require a minimum of three sources
The full story is for FNArena subscribers only. To read the full story plus enjoy a free two-week trial to our service SIGN UP HERE
If you already had your free trial, why not join as a paying subscriber? CLICK HERE